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ABSTRACT 
OBJECTIVE:  To  high-lighten  the  role  of  MR  mammography  as  a  pilot  pre-operative 
modality in the staging of breast cancer and its impact on surgical planning and management; 
aiming to decrease morbidity and mortality of this increasingly spreading cancer. In addition, 
to clarify the assessment of the relationship between the types of obesity and staging breast 
cancer. Moreover, to evaluate the diagnostic validity of breast MRI in discriminating benign 
from malignant lesions in women with suspected breast cancer histopathologic findings used 
as the golden standard. 
 
PATIENTS AND METHODS: Contrast-enhanced bilateral breast MRI was performed on 
60  women  with  suspected  breast  cancer  with  indeterminate  imaging  findings  by 
mammography  and/or  ultrasonography.  Lesions  detected  by  MRI  that  could  represent 
potential malignancies in both breasts were evaluated. Morphologic assessment and kinetic 
analysis  (contrast  enhancement)  were  performed  on  each  lesion  using  dedicated 
postprocessing and display software. Functional MR tools were used in few cases (6 cases) to 
help in the differential diagnosis between malignant and benign of suspicious lesions detected 
at conventional MRI. All patients underwent clinical and radiological evaluation followed by 
Contrast-enhanced bilateral breast MRI using 1.5-tesla superconductive Philips scanner and 
General Electric Medical Systems. The diagnostic images were evaluated as regard lesion 
morphology  (size,  shape,  margin  type,  enhancement  pattern),  signal  intensity  parameters 
(time  to  peak  enhancement,  maximum  slope  of  enhancement  curve,  washout),  and  the 
BIRADS categories. Results of the contrast enhanced bilateral breast MRI of the 60 patients 
were all reported and compared with the histopathalogical biopsy.  
RESULTS: A total of 60 patients presented with suspected breast cancer were included in the 
study with age ranging from 38 to 75 years old. 22 of the studied population had benign 
findings, while 38 of the patients were diagnosed as malignant. (18 patients IDC, 6 patients 
Invasive  Lobular  Carcinoma,  3  patient  Mucinous  carcinoma,  no  patients  Medullary 
carcinoma and 4 patients Insitu cancer). In this study population the sensitivity, specificity, 
positive and negative predictive values of mammography were found to be 51.6%, 88.4%, 
66.7%, and 80.3% respectively. Overall accuracy of mammography was 77%. Among the 38 
cases diagnosed by sonomammography as malignant or with irregular densities, 16 turned out 
to be benign by histopathological evaluation (false +ve), while among the 22 cases diagnosed 
by sonomammography to be benign lesions or non-conclusive studies (dense), 7 were proved 
to  be  malignant  by  histopathological  evaluation  (false  –ve).  The  sensitivity,  specificity, 
positive and negative predictive values of MRI for occult breast lesions in high risk patients 
included in the study, were found to be 100%, 93%, 86%, and 100% respectively. Overall 
accuracy of MRI breast was 95%. Among the 38 cases diagnosed by MRI as malignant, there 
was no false +ve, while among the 22 cases diagnosed by MRI to be benign lesions, 7 cases 
were proved to be  malignant by histopathological  evaluation (false  –ve). Therefore breast 
MRI had higher sensitivity than specificity but general speaking it is considered highly valid 
with high specificity also. Due to the limited number of cases in this study, there was a trend 
in relation of obesity (BMI) to breast cancer, malignancy rate 55.3% in obese women and 
44.7% in non-obese women. 
CONCLUSION: From  our study, we conclude that MR imaging  of  the breast in  obese 
women ,  is a rapidly evolving modality of excellent sensitivity in detection of breast cancer. 
The basic drawback of this modality was its low specificity for breast malignancy. However, 
multiple studies including this study have shown that with the improvement in equipment and 
technique there is gradual increase in specificity.  The Role of Pre-Operative Magnetic Resonance Mammography… 
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    Generally  speaking  breast  MRI  is  highly  effective  in  detection  and  characterization  of 
occult breast lesions in high risk population, with excellent sensitivity and high specificity. 
This  is  attributed  to  the  advance    most  in  equipment,  technique,  development  and 
implementation of interpretation guidelines and development of functional MRI tools which 
contributed to the improving validity of this modality. Also the superiority of MRI compared 
to  mammography,    supports  the  use  of  MRI  as  an  important  tool  in  screening  of 
asymptomatic women with high risk factors. 
 
INTRODUCTION  
Breast  cancer  is  the  most  common 
malignancy that affects women worldwide 
and  is  a  significant  health  care  problem 
(1).  Methods  such  as  X-ray 
mammography,  ultrasound  and  physical 
examination are often limited in sensitivity 
and  specificity,  especially  in  young 
women.  MRI  is  increasingly  being  used 
for preoperative local staging, localization 
of multiple lesions and screening of high-
risk patients, and it  is an area of intense 
research (2). 
   When added to the standard  evaluation 
in patients thought to have breast cancer, 
contrast-enhanced  MRI  using  both  a 
kinetic  and  morphologic  analysis  will 
often  result  in  changes  in  recommended 
patient  management,  better  treatment 
planning  and  detect  many  occult  cancers 
(3). 
    Breast MRI has a very high sensitivity 
of greater than or equal to 90% for breast 
cancer  and  near  100%  sensitivity  for 
invasive  breast  carcinoma.  Breast  MR 
imaging has been successfully used to help 
detect  sonomammographically  suspected 
breast cancer in women (4).  
 
PATIENTS AND METHODS: Contrast-
enhanced  bilateral  breast  MRI  was 
performed,  at  Ain  Shams  University 
hospitals and National Cancer Institute, on 
60 female patients with suspicious breast 
lesions: 30 normal control individuals and 
30 obese individuals. Their mean age was 
45 (age range, 15-77 years).  All patients 
were  with  suspicious  looking  imaging 
findings  by  Mammography  and/or 
Ultrasonography.  Lesions  detected  by 
MRI  that  could  represent  potential 
malignancies  in  both  breasts  were 
evaluated by morphologic assessment and 
kinetic  analysis  (contrast  enhancement) 
was  performed  using  dedicated  post-
processing and display software. 
 
 
• Inclusion Criteria: 
a.  Patient  presenting  with  breast 
pain/lump/nipple discharge 
b.  Obese  patients  included  in  the  stud" 
with BM1 > 30kg/m2 
c.  Women above the age of 25 years 
d. Serum Creatinine not more than > 1.4 
mg/dl. 
• Exclusion Criteria: 
a. Previous breast intervention 
b. Breast augmentation facilities 
c. Mulricenrricity diagnosed by U/S 
d. Serum Creatinine more than> 1.4mg/dL 
All  patients  were  subjected  to 
complete  clinical,  radiological  and 
anthropometric  evaluation  assessment. 
This  involved  thorough  history  taking 
including personal history, especially with 
respect  to  previous  breast  cancer  or 
biopsies  with  benign  histology,  family 
history  of  breast  or  ovarian  cancer, 
abnormalities  suspicious  of  malignancy 
(e.g., palpable mass, skin retraction, nipple 
discharge),  hormonal  status  and  previous 
allergic  reaction  after  administration  of 
MR  contrast  material.  Previous  imaging 
studies  such  as  mammography  and/or 
sonography,  and  their  findings  were 
evaluated  and  recorded.  Then  contrast-
enhanced  bilateral  breast  MRI  was 
performed and results of MRI examination 
were  compared  to  the  findings  from 
histopsthology and/or follow up. 
Patient  preparation:  There  is  no  specific 
preparation for different MR imaging such 
as fasting.  
•  MRI  examination  of  the  breast  in 
premenopausal women performed in the 
second or third week of the cycle, unless 
urgent. 
• Complete  screening  for  Ferromagnetic 
objects,  implanted  devices  (cosmetics/ 
surgical).  All  metallic  objects  were 
removed. 
•  Before  starting  the  MRI,  a  brief 
explanation  about  the  procedure  was Darine HA Saad et al 
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given to the patient with the prevention  of entire movement during the process  
A  venous  line  (18–20  G)  was  inserted 
prior starting the examination for contrast 
material administration.  
Scan  protocol:  MR  imaging  was 
performed  with  Philips  superconductive 
magnet  system  operating  at  1.5  Tesla 
using breast surface coils. The patient lies 
prone on the examination couch with her 
breast(s)  positioned  dependent  in  the 
receiver breast coil(s) and the arms placed 
along the body. Appropriate IV anesthetic 
agents  were  given  to  some  patients  who 
feared the MRI machine when needed. IV 
contrast  (gadolinium  chelates)  was  given 
for  assessment  of  tumor  kinetics.  Dose 
given  was  about  0.2  ml/kg  body  weight. 
Spine-echo  T1W1  was  performed  after 
contrast  administration.  The  routine 
protocol  applied  in  this  study  included 
Axial  T1,  T2,  Axial  T2  fat  suppressed, 
STIR  or  SPAIR  ±  Sagittal  STIR,  Axial 
Post-contrast  T1  WI  fat  suppressed  ± 
Sagittal  Post-contrast  3D  TFE  (T1  WI). 
Dynamic  3D  multiphase  post-contrast 
study was done in 6-8 minutes with MIP 
reconstruction (once before contrast and 4-
5  times  after  contrast,  each  around  1 
minute). For any region of interest (ROI), 
Time-Signal  intensity  curves  were 
performed. Signal intensity measurements 
were  performed  prior  to  as  well  as 
following  contrast  administration  in  this 
region of interest (ROI). ROIs are drawn at 
the  point  of  maximum  enhancement. 
Diffusion  weighted  imaging  +  ADC 
calculation were utilized in 59 cases. The 
field of view (FOV) typically ranged from 
280 to 340 mm, depending on the breast 
size.  The  slice  thickness  was  3  mm  or 
sometimes 2mm, and without gaps.  
 
Table (1) Physical parameters of different pulse sequences. 
  Axial 
T1WI 
Axial 
T2WI 
Axial/ Sagittal 
STIR 
Axial/ Sagittal 
+c 
T1WI 
Fat sat 
TR  540  4000-4800  2000-7500  485 
TE  10  120  55-170  10 
NEX  1  1  1  1 
ST  3mm  3mm  3mm  3mm 
Gap  0  0  0  0 
FOV  34x34cm  34x34cm  34x34cm  34x34cm 
Matrix  256x160 
or 256x192 
256x160 
or 256x192 
256x160 
or 256x192 
256x160 
or 256x192 
 
TR: Repetition time TE: Echo time NEX: 
Number of acquisition FOV: Field of view 
STIR:  Short  time  inversion  recovery  Fat 
sat: Fat saturation ST : Slice thickness. 
Data interpretation: All lesions or areas of 
abnormal  enhancement  detected  by  MRI 
that could represent potential malignancies 
in  both  breasts  were  evaluated,  by 
experienced MR radiologist, as regard: 
•  Morphology 
•  Exact Location  
•  Extent of involvement  
•  Signal  intensity  on  different 
pulse sequences  
•  Kinetics;  Enhancement  pattern 
and time/intensity curves  
• Vascularity of the lesion  
 
ACR BI-RADS–MRI Lexicon was used as 
a guideline for data collection. According 
to the BI-RADS Lexicon of the American 
College  of  Radiology,  suspicious 
enhancing  areas  in  the  breast  are 
differentiated  into  (a)  focus/foci,  (b) 
masses,  or  (c)  areas  of  non-mass-like 
enhancement.  Moreover,  associated 
findings  are  described  (10).  Masses  and 
areas  of  non-mass  like  enhancement  are 
subjected  to  careful  analysis  of  their 
morphology,  enhancement  kinetics,  and 
signal  intensity  patterns  on  T1-  and  T2-
weighted  images.  A  focus  is  a  small 
isolated  spot  of  enhancement,  generally 
less than 5 mm in size, that is so tiny that The Role of Pre-Operative Magnetic Resonance Mammography… 
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no definitive morphologic descriptors can 
be applied. A mass is a three-dimensional 
space-occupying  lesion  that  may  or  may 
not  displace  or  otherwise  affect  the 
surrounding  normal  tissue.  For  the 
evaluation of masses, different criteria are 
described. Criteria include shape, margin, 
endotumoral  type  of  contrast  internal 
enhancement,  and  the  initial  and  post- 
initial  signal  behavior  in  relation  to  the 
precontrast  signal.  Non-mass-like  lesions 
on MRI of the breast are enhancing areas 
that are neither a focus nor a mass. Non-
mass-like  enhancement  descriptions 
included  distribution,  internal 
enhancement  and  symmetry.  It  is 
described  as  a  focal  area,  linear,  ductal, 
segmental,  regional,  multiple  regions,  or 
diffuse.  Internal  characteristics  of  the 
enhancing  area,  like  homogeneous, 
heterogeneous,  stippled/punctuate, 
clumped,  or  reticular/dendritic,  is 
evaluated.  Associated  findings  (such  as 
edema,  adenopathy,  cysts,  and  skin  or 
chest  wall  involvement) are reported and 
kinetic  curve  assessment  of  all  lesions 
described.  The  analysis  of  enhancement 
kinetics included initial peak (Early phase) 
enhancement  and  delayed-phase 
enhancement  analyses,  by  measuring  the 
signal intensity in region of interest (ROI), 
and tracking its course over the  dynamic 
series (time–signal intensity curve). ROIs 
were  placed  into  the  area  that  exhibits 
strongest  enhancement  on  the  first 
postcontrast  image.  Early  Post  -contrast 
Phase  enhancement  describes  the 
steepness  of  the  first  part  of  the  kinetic 
curve,  indicating  the  velocity  and  degree 
with which enhancement occurs and may 
be slow, medium, or rapid. Delayed phase 
enhancement  refers  to  signal  intensity 
changes  that  occur  immediately  after  the 
early signal intensity increase which may 
(a) decline again; (b) exhibit a sharp bend 
and plateau; or (c) continue to rise after the 
early  phase,  yielding  persistent 
enhancement.  Enhancing  nodules  were 
assumed to be almost malignant when they 
showed  early  intense  enhancement  and 
progressive  signal  loss  over  time 
(washout),  whereas  lesions  showing 
progressive  enhancement  over  time  were 
assigned  to  be  more  likely  benign  (13). 
(Fig. 1) 
 
 (Fig. 1) : Schematic drawing of time-signal intensity curve types. Type I (persistent or steady 
curve) corresponds to a straight (Ia) or curved (Ib) line. Type II (plateau curve). Type III 
(Washout curve) (37). 
 
         Using  ACR  BI-RADS–MRI 
Lexicon,  lesions  were  categorized  into 
seven categories according to the findings 
of  the  breast  MRI.  MRM-BI-RADS  0 
describe an incomplete assessment and the 
category  MRM-BIRADS  6  is  given  to  a 
histological verified breast carcinoma. The 
other  five  categories  include:  Category 
MRM-BI-RADS  1:  “negative”  No 
abnormal enhancement is found. Category 
MRM-BI-RADS 2: “benign” MRI shows a 
benign  finding,  for  example  a  hyalinized 
nonenhancing  fibroadenoma,  cysts,  and 
old  nonenhancing  scars,  fat-containing Darine HA Saad et al 
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lesions  such  as  oil  cysts,  lipomas, 
galactoceles,  or  mixed-density 
hamartomas. Category MRM-BI-RADS 3: 
“probably benign” Changes that are highly 
unlikely  to  be  malignant,  i.e.,  those  that 
have  a  very  high  probability  of  being 
benign,  are  placed  in  this  category. 
Category MRM-BI-RADS 4: “suspicious” 
These  are  lesions  that  do  not  have  the 
characteristic  morphology  of  breast 
carcinoma, but do have a definite low to 
moderate  probability  of  being  malignant. 
Category  MRM-BI-RADS  5:  “highly 
suggestive  of  malignancy”  Lesions 
categorized as MRM-BI-RADS 5  have a 
high probability of being cancerous. They 
show the typical  findings  of a  malignant 
breast tumor 
DISCUSSION 
  Breast  cancer  is  the  most  common 
cancer, and is the second leading cause of 
cancer-related  mortality  in women. Thus, 
prevention  and  screening  have  become 
important  health  issues.  Early  detection 
and treatment at proper time lead to good 
prognosis. (5) 
The  sensitivity  of  mammography 
to detect breast cancer decreases in women 
with  dense  breast.  This  disadvantage  of 
mammography  has  become  more 
important in the recent years which have 
witnessed  a  substantial  increase  in  the 
incidence  of  malignancy  in  the  young 
women (6). 
One  of  the  major  limitation  of 
mammography  is  the  overlap  in  the 
appearance  of  benign  and  malignant 
lesions .Some of the abnormal densities on 
the  mammograms are actually caused by 
superimposition  of  normal  densities  ,not 
all  patients  with  suspected  densities  on 
mammography  would  have  breast  cancer 
(7). 
The overlap in the mammographic 
appearance  and  physical  examination 
findings of benign and  malignant  lesions 
results  in  a  relatively  high  number  of 
benign breast biopsies, unnecessary patient 
anxiety  and  morbidity  related  to  biopsy 
(8). 
The  high  benign  biopsy  rate  has 
generated significant interest in adjunctive 
imaging  tests  that  would  improve  the 
positive predictive value of the diagnostic 
work  up.  The  classic  example  of  an 
adjunctive  modality  that  has  been 
successfully used to improve specificity is 
sonography . 
 US  has  never  been  important  in 
breast disease management as it is today. 
Its historical role as an adjunct modality to 
mammography  in  differentiating  cystic 
from  solid  lesions  has  been  widely 
expanded. US guided sampling procedures 
represent  a widely accepted  modality  in 
lesion evaluation .Preoperative localization 
under US guidance is one of the methods 
of  choice  for  non  palpable  solid  lesions. 
However, the main limitation of US  is its 
operator  dependent  nature  ,  and  many 
other factors.(9). 
The  role  of  MRI  in  evaluating 
breast  disease  has  been  studied  and 
debated since contrast enhanced MRI was 
introduced  in  1985.Interset  has  grown 
steadily as evidence of its usefulness has 
accumulated (10). 
Breast  magnetic  resonance 
imaging is emerging as an important tool 
for  the  detection  and  characterization  of 
breast  cancer  .The  value  of  breast  MR 
imaging is derived primarily from the high 
sensitivity  of  contrast  material 
enhancement  in  the  detection  of  breast 
cancer .The characterization of lesions as 
benign  or  malignant  on the basis  of MR 
imaging  characteristics  remains  a 
challenge (8). 
Breast  MRI  is  continually 
recognized for its high sensitivity in breast 
cancer  detection,  which  in  some  studies 
approaches 100%. Although not currently 
recommended for routine screening, breast 
MRI  may  benefit  women  with  high-risk 
factors  including  genetic  predisposition, 
dense breast composition, personal history 
of breast cancer, atypia, lobular carcinoma 
in  situ,  and  family  history.  MRI  can 
provide  additional  information  for 
evaluating the extent of disease in women 
diagnosed  with  breast  cancer,  including 
identification  of  multicentric  and 
multifocal disease in the ipsilateral breast 
and  additional  sites  of  cancer  in  the 
contralateral  breast.  Patients  who  have 
undergone  a  lumpectomy,  patients  with 
positive  axillary  nodes  and  unknown 
primary  carcinomas,  and  patients  with 
breast  implants  may  also  benefit  from 
breast MRI. (11) The Role of Pre-Operative Magnetic Resonance Mammography… 
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In  this  study,  we  attempted  to 
investigate  the  validity  of  MRI  in 
characterization of suspected breast lesions 
and  to  verify  the  improvement  in  its 
validity,  particularly  specificity,  achieved 
by implementing combined qualitative and 
quantitative MR tools.  
 This study included 60 patients (15 to 75 
years)  with  suspected  breast  lesions, 
among which 38 patients turned out to be 
malignant. 
Mammographic  evaluation  of  the 
lesions  was  based  on  Breast  Imaging 
Reporting  and  Data  System  (BI-RADS) 
with classification of these lesions into BI-
RADS  0  which  was  assigned  for  seven 
lesions  with  very  dense  breast,  their 
further  classification  was  based  on  US 
findings. BI-RADS II were included in our 
study  as  being  accidently  discovered  in 
association  with  suspicious  findings  or 
being up graded after US  evaluation and 
they  represented  three  lesions.  BI-RADS 
III  and  BI-RADS  IV  were  our  main 
concern in this study  respectively. 
Although  increasing  age  is  the 
single  most  important  risk  factor  for 
developing breast cancer (12), yet the rate 
at  which  risk  rises  declines  significantly 
around  age  50  years.  Therefore  breast 
cancer  incidence  is  higher  in  relatively 
younger  age  groups  than  in  the  general 
population. (13) This was reflected among 
the studied population who were presented 
with  suspicious  lesions  of  breast  cancer, 
around  85%  of  cancer  cases  were 
presented in the 38-75 years age group. 
A  projection  of  the  future  health 
and  economic burden  of  obesity  in 2030 
estimated  that  continuation  of  existing 
trends  in  obesity  will  lead  to  about 
500,000 additional cases of cancer in the 
United States by 2030. This analysis also 
found  that  if  every  adult  reduced  their 
BMI  by  1  percent,  which  would  be 
equivalent to a weight loss of roughly 1 kg 
(or 2.2 lbs) for an adult of average weight, 
this  would  prevent  the  increase  in  the 
number of cancer cases and actually result 
in  the  avoidance  of  about  100,000  new 
cases of cancer. 
     The  relationship  between  obesity  and 
breast cancer may be affected by the stage 
of life in which a woman gains weight and 
becomes obese. Many studies revealed that 
weight  gain  during adult life,  most often 
from about age 18 to between the ages of 
50  and  60,  has  been  consistently 
associated with risk of breast cancer after 
menopause.                                                                                                     
(13) 
  The evidence for anthropometric factors 
influencing  breast  cancer  risk  is 
accumulating,  but  uncertainties  remain 
concerning the role of fat distribution and 
potential  effect  modifiers.  Study 
performed by Lahmann PH et al.,2011  for 
5  years  duration;  73,542  premenopausal 
and 103,344 postmenopausal women from 
9  European  countries,  taking  part  in  the 
study;  categorized  by  cohort-wide 
quintiles;  and  expressed  as  continuous 
variables,  adjusted  for  study  center,  age 
and  other  risk  factors.  Weight,  BMI  and 
hip  circumference  were  positively 
associated with breast cancer risk (p < or= 
0.002);  obese  women  (BMI  >  30)  had  a 
31% excess risk compared to women with 
BMI < 25. 
     In  this  study,  by  One-  Sample  Test 
study revealed that there was statistically 
non-significance  difference  of  benign  to 
malignant relation in correlation to height 
(P  value  0.345),  mid-upper  (P  value 
0.758), waist (P value 0.349) and  hip (P 
value  0.933)  circumferences.  However, 
mid-  arm  circumference  showed 
statistically  significance  <0.001, 
mimnimum 23.0 and maximum 77.0. 
      Due to the limited number of cases in 
this study, there was a trend in relation of 
obesity  (BMI)  to  breast  cancer  , 
malignancy  rate  55.3%  in  obese  women 
and 44.7%  in non obese women. 
      Lahmann PH et al., (14) revealed that 
the  hip  circumference  in  the 
premenopausal  women  was  the  only 
measureable significantly related to breast 
cancer  (p  =  0.03),  after  accounting  for 
BMI.  In  postmenopausal  women  not 
taking  exogenous  hormones,  general 
obesity is a significant predictor of breast 
cancer,  while  abdominal  fat  assessed  as 
waist-hip ratio or waist circumference was 
not  related  to  excess  risk  when  adjusted 
for BMI. Among premenopausal women, 
weight  and  BMI  showed  nonsignificant 
inverse associations with breast cancer. 
   The factor of pre- and post- menopausal 
effect on obesity in relationship to breast Darine HA Saad et al 
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cancer was not discussed in this study, that 
was a drawback.  
 Until  recently,  the  use  of  breast  MR 
imaging  for  screening  was  greatly 
discouraged. This has changed, mthat MR 
is  increasingly  used  for  screening  in 
selected  subsets  of  women  with  an 
increased  lifetime  risk  for  breast  cancer. 
An increased risk for breast cancer can be 
due  to  (a)  a  personal  history  of  breast 
cancer;  (b)  a  history  of  a  breast  biopsy, 
with  “borderline”  biologic  behavior  such 
as radial scar, lobular carcinoma in situ, or 
atypical ductal hyperplasia; (c) a history of 
mediastinal  irradiation  for  Hodgkin 
disease;  or  (d)  a  familial  clustering  of 
breast  and/or  ovarian  cancer.  For  all  of 
these  subgroups,  breast  MR  imaging  has 
been  successfully  used  to  help  detect 
mammographically  and  sonographically 
occult breast cancer. (15) 
In the current study, we included 
patients who are at high risk of developing 
breast cancer  with indeterminate imaging 
findings  by  mammography  and/or 
ultrasonography  and  their  MRI 
examination revealed occult breast lesions 
not  seen  by  other  imaging  modalities  or 
helped  in  determining  the  nature  of 
previously detected equivocal lesions. 
The histopathalogical types of the 
38 malignant biopsies (in our study were 
as  following:  18  cases  IDC  (47.4%),  6 
cases invasive lobular carcinoma (15.8%), 
3 cases mucinous carcinoma (7.9%) and 2 
cases  DCIS  (5.3  %).  No  cases  with 
medullary  carcinoma  was  detected.  The 
commonest  location  of  the  malignant 
masses within the breast tissue was in the 
multi- quadrants 34.20 % and upper outer 
quadrant  28.90%,  of  the  lesions  were 
located.  
Our findings agree with Bleiweiss 
et al (16). They stated that the two main 
histologic types of invasive carcinoma of 
the breast are invasive duct carcinoma and 
invasive lobular carcinoma. Together they 
constitute the vast majority of infiltrative 
malignancies  that  will  be  encountered  in 
routine  practice.    Van  de  Vijver(17) 
mentioned the estimated frequency of each 
histologic type  of invasive breast cancer; 
Invasive Ductal carcinoma (not otherwise 
specified)  70%,  Invasive  Lobular 
carcinoma  10%,  Tubular  carcinoma  5%, 
Mucinous  carcinoma  5%,  Medullary 
carcinoma  3%,  Atypical  Medullary 
carcinoma  3%  and  others  4%.  These 
frequencies are also however reflected in 
our study. 
Of  all  breast  imaging  techniques 
that  are  currently  available,  including 
mammography,  breast  US,  positron 
emission  tomography,  and 
scintimammography,  MR  offers  the 
highest  sensitivity  for  invasive  breast 
cancer.  Published  sensitivity  levels  range 
between 89% and 100%. In all studies that 
can  be  found  in  the  literature,  the 
sensitivity of MR imaging was higher than 
that  of  mammography.  The  degree  to 
which  the  sensitivities  of  mammography 
and breast MR imaging differ in the same 
patients  depend  on  the  mammographic 
breast  density  and  the  type  of  breast 
cancer:  The  difference  increases  with 
increasing  breast  density  and  for  cancers 
that are difficult to diagnose on the basis 
of  mammographic  findings.  The  latter  is 
the  case,  for  example,  in  cancers  with  a 
diffuse  growth  pattern,  such  as  invasive 
lobular cancers, and in cancers that exhibit 
benign  morphologic  features,  such  as 
medullary cancer. The sensitivity of breast 
MR  imaging  is  not  impaired  by  the 
amount  or  density  of  the  fibroglandular 
tissue. (15) 
Overlooking  invasive  breast 
cancer  on  MR  images  is  rare,  but  it 
certainly  does  happen.  Non-enhancing 
invasive  breast  cancers  are  exceedingly 
rare. More often, the reason for failure to 
diagnose invasive cancer with breast MR 
imaging is early and strong enhancement 
in  the  surrounding  normal  fibroglandular 
tissue  that  may  mask  the  enhancing 
cancer.  (15) 
In  this  study,  we  compared  the 
results of MRI and sonomammography in 
the  study  population  to  the  findings  of 
histopathology.  Mammographic 
examination of the breast lesions  yielded 
an  overall  sensitivity  of  66.7%,  a 
specificity  of  93.8  %  and  accuracy  of 
74.1%.Our  result  is  comparable  to 
previous  studies  that  reported  the 
sensitivity of mammography ranged from 
63 % (18) to 81.8 % (19) .On the  other 
hand, specificity of mammography ranged 
from 70% (18) to 99% (19). The Role of Pre-Operative Magnetic Resonance Mammography… 
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This  studied  agreed  with  Bassett 
and  Kim,  2001  that the  breast  density  is 
one of the most important factors limiting 
the sensitivity of mammography and that 
was  encountered  in  seven  cases  in  our 
study.  
However,  the  high  specificity  of 
mammography  in  our  study  may  be 
attributed to selection of our cases unlike 
studies which evaluated general population 
and healthy women who undergo periodic 
screening.   
The  results  of  the 
sonomammographic  examinations  of  the 
patients were;   38% of the studied cases 
had  dense  breasts  in  sonomammography 
which  hindered proper assessment  of the 
breast masses, normal sonomammography  
11.67%    were  detected,  6.67%  were 
categorized  as  BIRADS  II  (probably 
benign),  33.33%  were  categorized  as 
BIRADS  III  and  48.33%  BIRADS  IV 
(probably malignant). 
Among the 38 cases diagnosed by 
sonomammography  as  malignant  or  with 
irregular  densities,  16  turned  out  to  be 
benign  by  histopathological  evaluation 
(false  +ve),  while  among  the  22  cases 
diagnosed  by  sonomammography  to  be 
benign  lesions  or  non-conclusive  studies 
(dense), 7 were proved to be malignant by 
histopathological  evaluation  (false  –ve). 
Among  the  28  cases  that  had  dense 
breasts,  7  cases  turned  out  to  have 
underlying malignant masses, 15 cases had 
underlying benign pathologies and the rest 
were  free.  All  these  lesions  were  readily 
identified in MRI.  
Therefore  our  results  agree  with 
Morrow  et  al,(20)  who  stated  that, 
compared with mammography, MRI has a 
higher  sensitivity  for  the  detection  of 
breast cancer and is not affected by breast 
density. 
The  overall  calculated  US 
sensitivity,  specificity  and  accuracy  were 
83.7%, 87.5% and 84.8 % respectively. 
Most  of  the  previous  studies 
showed that the sensitivity of MR imaging 
for detection of breast cancer is very high, 
and  approaches  100%  for  invasive 
carcinoma.  However  the  specificity  is 
lower and varies widely between different 
studies.  The  factors  associated  with  this 
wide range of specificity are differences in 
the study population, strength of magnet, 
imaging  protocols,  and  interpretation 
criteria. (21) 
In  a  study  done  by  Baltzer  et 
al(22),  they    stated  that  false  positive 
findings  occur  and  lead  to  unnecessary 
biopsy  and  concluded  that  non-mass 
lesions  were  the  major  cause  of  false-
positive breast MRI findings. 
Some  studies  were  done  to 
improve  specificity.  A  study  done  by 
Khatri  et  al(23)showed  that  improved 
specificity  could  be  obtained  by 
quantification of lesion enhancement. This 
method  involved  complex  mathematical 
analysis. Another Study done by Siegman 
et al(24) showed that both qualitative and 
quantitative  lesion  characteristics  were 
required for lesion differentiation. 
Therefore  the  basic  drawback  of 
this  modality  was  low  specificity  for 
breast  malignancy.  Multiple  studies  have 
shown  that  with  the  improvement  in 
equipment and technique there is gradual 
increase in specificity. (5) 
The  growing  role  of  MRI  in  the 
evaluation of breast cancer in symptomatic 
women  has  identified  that  MRI  may 
provide  a  sensitive  method  for  screening 
women for breast cancer. (25) 
The data regarding the specificity 
and positive predictive value for screening 
MR are less concordant: A higher rate of 
false-positive  diagnoses  for  MR  imaging 
than for mammography has been reported 
in several studies (26), (27), (5). The study 
by Warner et al (27) provides a possible 
explanation for this:  Whereas the rate  of 
false positive MR  diagnoses  was  high at 
the beginning of the breast MR screening 
project,  the  rate  decreased  from  year  to 
year  to  reach  the  same  level  as  that  for 
mammography, where mammography and 
MR  exhibited  equivalent  positive 
predictive  values.  This  observation,  as 
well  as  the  results  from  other  studies 
(28),(15),(29) suggests that a high rate of 
false-positive diagnoses is not inherent to 
the  technique  of  breast  MR  imaging. 
Rather, it is due to limited experience with 
breast MR in a screening setting. (15) 
In  our  study  the  sensitivity, 
specificity,  positive  and  negative 
predictive  values  of  MRI  for  suspected 
breast lesions included in the study, were Darine HA Saad et al 
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found to be 100%, 93%, 86%, and 100% 
respectively.  Overall  accuracy  of  MRI 
breast was 95%.  
Among the 38 cases diagnosed by 
MRI  as  malignant,  0  turned  out  to  be 
benign  by  histopathological  evaluation 
(false  +ve),  while  among  the  15  cases 
diagnosed by MRI to be benign lesions, 7 
were  proved  to  be  malignant  by 
histopathological evaluation (false –ve) 
It  is  becoming  increasingly  clear 
that  while  most  investigators  have  used 
either  enhancement  kinetics  or  lesion 
morphology in an attempt to differentiate 
malignant  from  benign  lesions  on 
contrast–enhanced  MR  imaging  studies, 
the  integration  of  both  kinetic  and 
morphologic  information  may  ultimately 
be  needed  to  achieve  optimal 
discrimination (7). 
In  general  margin  and  shape 
analysis should be performed on first post 
contrast  image  to  avoid  wash  out  and 
progressive  enhancement  of  the 
surrounding breast tissue (30).     
Macura  et  al.,(31)found  that  the 
description of the margin of a focal mass 
is the most predictive feature of the breast 
MR  image  interpretation.  Speculated 
margins  are  suspicious  for  carcinoma, 
having  91%  positive  predictive  value 
(PPV) for malignancy. 
In  concordance  with  Macura  et 
al.,(31)speculated  margins  in  our  study, 
having (100% specificity and 100% PPV) 
being  encountered  only  in  malignant 
lesions                  The  calculated  P  value, 
sensitivity and specificity of mass margin 
in  differentiating  benign  from  malignant 
was 0.001, 93.1% and 52.17% respectively 
. 
Moreover,  Kuhl(15)found  that 
some  of  the  most  powerful  diagnostic 
criteria  for  the  differentiation  of  benign 
and  malignant  tumors  belong  to  internal 
enhancement of focal mass . He reported 
that  dark  septations  if  present  within  a 
lobular  or  oval  mass  are  typical  of 
fibroadenomas 
Also, we found in our study, that  
non  enhancing  internal  septa  were  only 
found in benign lesions (3 lesions) proved 
to  be  fibroadenomas  by  histopathology. 
The calculated P value of non enhancing 
internal  septa  was  statistically  significant 
(< 0.005).  
Tozaki  et  al,(32)reported  that  the 
most  frequent  morphological  findings 
among  the  malignant  lesions  was 
heterogeneous internal enhancement.  
In  our  study  11  benign  lesions 
exhibited  heterogeneous  enhancement, 
their  pathological  diagnosis  was  mastitis 
and  fibroadenomas.  Ring  enhancement 
was found in 5 benign cases proved to be 
fibroadenosis  with  fibroadenomatoid  and 
cystic changes. Homogenous enhancement 
was found in 20 lesions, 11 were benign 
and  9 were malignant. 
Thus  in  our  study,  there  was  no 
statistical  correlation  between  the 
pathologically  proven  benign  and 
malignant  lesions  regarding  their 
enhancement  pattern  except  the  non 
enhancing internal septa and this may be 
attributed to the small number of studied 
patients, however all our   pathologically 
proven  benign  cases  did  not  show 
enhancing  internal  septa  (100  % 
specificity)  and  all  lesions  showed 
enhancing  internal  septa  were  malignant 
(100%PPV).   
We  encountered  seven  lesions  of 
non  mass  like  enhancement,  5  of  them 
showing  ductal  enhancement  and  were 
interpreted  as  suspicious  MRI  findings,2 
of them  proved to be  benign (duct ectasia 
with  periductal  mastitis)    and  3  were 
malignant  (invasive  duct  carcinoma).The 
remaining  2  lesions  were  of    regional 
enhancement and proved pathologically  to 
be invasive cancer with insitu component 
,in  which  tumor  extension  was    well 
delineated by MRI  examination. 
Kuhl,(33) reported that the lesion 
enhancement rate in the early post contrast 
period  serves  as  a  differential  diagnostic 
criterion with malignant lesions exhibiting 
stronger  and  faster  enhancement  than 
benign  changes  do.  Yet,  a  considerable 
number  of  benign  proliferative  changes 
and  benign  solid  tumors  demonstrate 
enhancement rates comparable to those of 
malignant  lesions,  thus  reducing  the 
technique specificity. 
In this study, there was an overlap 
in  the  enhancement  rate  of  benign  and 
malignant lesions ranging from 25 to 120 
%  (in  benign  lesions)  and  from  30  to The Role of Pre-Operative Magnetic Resonance Mammography… 
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280%  (in  malignant  lesions).  Our 
calculated  P  value  was  insignificant 
(>0.005), this is comparable with the study 
of  Kuhl  et  al,  2005  who  reported  that 
enhancement  rates  proved  to  be  not 
diagnostically  relevant  because  of  the 
broad  overlap  between  benign  and 
malignant  lesions  and  were  therefore  of 
only  limited  diagnostic  use  in  the 
individual patient.  
 The  variability  of  quantitative 
methods  and  the  overlap  in  the 
enhancement  kinetics  in  the  early  post 
contrast    enhancement  period  of  benign 
and  malignant  lesions  have  led 
investigators to seek a qualitative approach 
to lesion enhancement, in which the shape 
of the entire time -signal intensity curve is 
qualitatively assessed. Use of these time- 
signal  intensity  curves  resulted  in 
dramatically higher specificity (83%) and 
accuracy( 86%) than were obtained when 
enhancement  rate  specificity  (37%)  and 
accuracy (58%) was used (7). 
We calculated the P value of each 
type of time signal intensity curve  and we 
found that progressive  (type I ) and the 
wash out (type III)  curves were  found in 
7  and    4    pathologically  proven  benign 
lesions compared to 4 and 38  malignant  
lesions respectively. So their calculating  P 
value  was  significant  (<0.005)  in 
differentiation  benign  from  malignant 
lesions with progressive type curve more 
observed in benign findings and wash out 
curve more with malignant findings . On 
the contrary ,the  P value  of plateau (type 
II  )    was  insignificant  (>0.005)  being 
present in 11 benign lesions compared to 4 
malignant lesions.   
In this study, the calculated MRI 
sensitivity  was  90.7%,  specificity  was 
68.8%,  NPV  and  PPV  was  73.3%  and 
88.6% respectively .This was based on the 
combination  of  morphologic  and  kinetic 
criteria (34) 
We  observed  that  three 
pathologically  proven  malignant  lesions 
were falsely classified as probably benign 
findings  based  on  BIRADS  Lexicon 
system. For example one of those lesions 
was  invasive  lobular  carcinoma  that 
exhibited  regular  shaped,  well-defined 
mass  of  homogenous  enhancement  as 
morphologic  criteria,    37%  enhancement 
rate and wash out curve as kinetic criteria 
.So  its  scoring  system  was  3  consisting 
with  BI-RADS  III  category  .In  order  to 
increase the sensitivity and specificity  of 
MRM  we  followed  the  guidelines  
described by Kuhl   et al,(15) concerning 
MRI  BI-RADS  category  stated 
classification  of  lesion  as  BI-RADS  IV 
with a wash out time curve, irrespective of 
its  morphology  or  lesion  with  suspicious 
morphology irrespective of its  kinetics. 
Our results were comparable with 
the  study  of    Seely  et  al,  2007  who 
reported  that  BI-RADS  categorization  in 
breast MRI had the highest combination of 
specificity  and  sensitivity(77.1%and 
81.8%)..  
An assessment of probably benign 
is clinically helpful when used for a lesion 
that is not definitely benign and that can 
be  followed  safely  with  short  term 
imaging  surveillance  rather  than  biopsy 
(35).Leung  2010  (36)  stated  that  MR 
imaging  has    a  high  negative  predictive 
value  in  excluding  breast  cancer,  so  it 
plays a role in the evaluation of selected 
clinical and imaging findings of the breast, 
especially when biopsy is not technically 
feasible. Case selection is very important 
in ensuring the efficacy of this use of MR 
imaging because of potential false-positive 
and false-negative results.  
Concerning  BI-RADS  III  lesions 
our  calculated  NPV  of  MRM  was  high 
(90.9%)  compared  to  that  of 
sonomammography  (77.8%).With  9.1% 
false negative rate, which dose not obviate 
completely  further need for tissue biopsy 
or  recommendation  for  follow  up  after 
MRI examination 
    Therefore,  breast  MRI  had  higher 
sensitivity  than  specificity  but  generally 
speaking it is considered highly valid with 
high  specificity  also.  We  found  that 
combining  qualitative  assessment  of 
morphological  appearance  of  lesion  on 
post  contrast  study  and  time  signal 
intensity curves with functional MR tools, 
which were utilized in about few (6 cases) 
of  the  study  population,  was  useful  for 
achieving high validity for breast MRI. 
Therefore,  we  agree  with 
Liberman(37) who claimed that MRI can 
detect otherwise suspected breast cancer.  Darine HA Saad et al 
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Lord  et  al.(38)considered  the 
value of adding MRI to mammography or 
mammography  plus  ultrasound  and  or 
clinical  breast  examination,  concluding 
that adding MRI results in the detection of 
additional cancers, but that any  mortality 
benefit is unknown. The overview of five 
studies calculated an overall sensitivity of 
80.7%  for  MRI  and  39.5%  for 
mammography    (38).  Bermejo-Perez  et 
al.(39)  reported  similar  conclusions.  An 
older review by Liberman (37) stated that 
in  3  studies  that  supplemented 
mammography  with  both  MRI  and 
ultrasonography,  MRI  had    a  higher 
sensitivity  and  specificity  than 
ultrasonography  and  was  superior  in 
detecting ductal carcinoma in situ.   
Yoshikawa et al (40) performed a 
study to investigate breast cancer-detecting 
ability  of  diffusion  weighted  magnetic 
resonance  imaging  (DW-MRI)  by 
comparing  the  breast  cancer  detection 
rates  of  DW-MRI  and  mammography 
(MMG) in 48  women. The breast cancer 
detection  rates  by  MMG  and  DW-MRI 
were  84.9%  and  94.3%  (statistically 
significant  P  <  0.001),  respectively.  In 
each  classification  of  histology  and  size, 
the detection rate by DW-MRI was higher 
than  that  by  MMG.  In  relation  to  the 
mammary  gland  density,  the  detection 
rates  of  fatty,  scattered,  heterogeneously 
dense,  and  extremely  dense  mammary 
glands were 100%. 
Our results agreed well with these 
studies  mainly  as  regard  the  high 
sensitivity  of  MRI.  This  could  be 
attributed  to  using  functional  MRI  tools, 
mainly  diffusion  weighted  images  which 
was done in few (6 cases)  and helped to a 
great extent in highlighting the pathology 
among  the  normal  enhancing  glandular 
tissues.  
     This  explains  the  excellent  sensitivity 
of  MRI  that  we  achieved  in  this  study 
(100%) and the ability of MRI, including 
DWI,  to  detect  the  lesions  which  were 
none  visualized  in  mammography 
particularly in dense breasts. 
   Metastases  to  the  breast   from  non-
mammary primary tumours are uncommon 
and  account  for  0.5-2.0%  of  all  breast 
malignancies.  In  this  study,  8%  of  the 
cases  were  secondary  metastasis  ;  Non-
Hogkin Lymphoma and Thyroid cancer. 
       MRI  systems  at  3.0  T  are  now 
available  from  several  major  MRI 
manufacturers.  3.0  T  machines  have  the 
advantage of higher signal-to-noise ratios 
(SNR)  which  can  be  traded  for  higher 
spatial  resolution,  higher  temporal 
resolution, or both. New techniques, such 
as  hydrogen  spectroscopy,  would  also 
benefit  from  the  use  of  3  T  systems  in 
terms of increased spectrum resolution and 
higher  SNR.  (41)Therefore  the 
introduction  of  these  high  field  systems 
into  clinical  practice  is  expected  to 
contribute  further  in  the  improvement  of 
the  validity  of  MRI  making  it  more 
superior in comparison to other available 
imaging modalities. 
Because  investigators  of  breast 
MR  imaging  have  reported  higher 
sensitivities  and  specificities  for  MR 
imaging  compared  with  those  for 
mammography, it has been suggested that 
MR  imaging  could  be  used  to  further 
characterize indeterminate lesions detected 
at  mammography,  US  or  physical 
examination(7) The reported sensitivity of 
MRI    for  the  visualization  of  invasive 
breast  cancer  have  approached  100%  in 
several  studies,  while  the  reported 
specificities  have    been  very  variable, 
imaging from 37%to 97%(7) 
  Therefore,  Breast  MRI  is  highly 
valid;  however  its  disadvantages  include 
cost,  variations  in  technique  and 
interpretation,  variation  in  parenchymal 
enhancement  during  the  menstrual  cycle, 
exclusion  criteria  (e.g.,  the  presence  of 
pacemakers  or  aneurysm  clips  or  a 
patient’s claustrophobia), and an unproved 
survival benefit.(37) 
Hiwatsch  et  al,  (18)reported  that 
although MR imaging is most sensitive for 
detection  of  breast  tumor,  routine 
preoperative  MR  appears  to  be 
unnecessary  for  most  patients  if 
combination of mammography and whole 
breast sonography is used. 
All breast imaging modalities have 
either  "blind  spots"  or  specific  strength 
and  weakness  .It  is  unlikely  that  the 
diagnostic  accuracy  of  an  imaging 
technique  will  be  superior  to  that  of 
another in each and every clinical scenario The Role of Pre-Operative Magnetic Resonance Mammography… 
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. Accordingly, rather than compare overall 
negative  predictive  values  of  imaging 
modalities  ,one  should  identify  specific 
clinical situations for which it may well be 
feasible  to  use  MR  imaging  for  problem 
solving and others for which the same is 
not  attainable  because  the  NPV  is  high 
enough (15) 
Although  our  results  are 
comparable  to  most  of  the  previous 
studies,  still  there  are  a  few  limitations. 
The  number  of  patients  included  in  the 
study  was  limited  by  the  relatively  short 
duration of the study and limited number 
of  patients  who  undergo  breast  MR 
examinations  and  fit  to  our  inclusion 
criteria. This is because of the cost factor 
and  relative  lack  of  awareness  regarding 
usefulness  of  MR  imaging  for  the 
diagnosis of breast cancer.  
At  the  end  of  our  study,  we 
conclude that MR imaging of breast is a 
rapidly  evolving  modality  of  excellent 
sensitivity  in  detection  of  breast  cancer 
especially  in  obese  patients.  The  basic 
drawback  of  this  modality  was  low 
specificity  for breast  malignancy and the 
limitation of the coils size (extremely large 
breasts).  However,  multiple  studies 
including this study have shown that with 
the  improvement  in  equipment  and 
technique  there  is  gradual  increase  in 
specificity.  
Generally speaking breast MRI is 
highly  effective  in  detection  and 
characterization  of  suspected  breast 
lesions, with excellent sensitivity and high 
specificity.  This  is  attributed  to  the 
advance  in  equipment,  technique, 
development  and  implementation  of 
interpretation guidelines and development 
of functional MRI tools which contributed 
to the improving validity of this modality. 
Also the superiority of MRI compared to 
mammography,  supports  the  use  of  MRI 
as  an  important  tool  in  screening  of 
asymptomatic high risk women.    
We suggest that further studies are 
needed  to  develop  confidence  in  this 
emerging imaging modality should include 
implementation  of  the  Multiparametric  
concept  and  utilize  the  functional  MRI 
tools, which is expected to aid for better 
patient  management  and  to  avoid 
unnecessary  biopsies  by  eliminating  the 
false positive results that sometimes occur 
when using breast MRI. 
Case (1) 
Obese 43 years old patient  
Clinical presentation 
Left breast painless lump 
 and bloody nipple discharge  
Anthropometric parameters 
Wt:98kg 
Ht:160m 
Circumferences; 
•  Mid upper arm:47cm 
•  Waist:110cm 
•  Hip:150cm   
•  BMI:38.28 
Mammographic findings 
(Fig.a):Medio-lateral  view  of  the  left  breast  showing  LIQ  dense  central  architectural 
distortion (BI-RADS III-IV).  
 
(Fig.a):MLO view mammogram of the left breast Darine HA Saad et al 
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Sonographic findings 
(Figs.b,c):A speculated heterogenous mass at 3 o’clock  region casting posterior shadowing 
with ipsilateral retro-areolar ductectasia (BI-RADS III/IV). 
 
(Fig.b):Left speculated heterogenous mass 
 
(Fig.c):Left retro-areolar ductectasia 
 
Dynamic MRM findings 
(Figs.d,e):Post contrast T1 WI  fat suppression  and Subtracted WI images at the same 
axial plane showing LIQ non mass ductal enhancement with deep extension. (Fig.f) Time 
signal intensity Type III malignant Wash out curve  (BI-RADS IVc). 
 
 
(Fig.d): Post contrast T1WI  of the left breast 
 
(Fig.e):Subtracted MR image of the left 
breast 
 
(Fig.f):Time- signal intensity Type III curve 
Wash out 
PathologyInvasive duct carcinoma grade III.  
 The Role of Pre-Operative Magnetic Resonance Mammography… 
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Case (2) 
 
Non obese 56 years old patient 
Clinical presentation 
Right breast multiple painful lumps  
Anthropometric parameters 
Wt:89kg 
Ht:182m 
Circumferences; 
•  Mid upper arm:40cm 
•  Waist:88cm 
•  Hip:94cm 
BMI:26.87 
Mammographic findings 
(Fig.a):Cranio-caudal view of both breasts and magnified image of the left breast showing 
right UOQ multiple variable in size and shape dense masses with partially ill defined margins 
in some (BI-RADS IVa). (arrows)  
(Fig. b):Left breast LIQ suspicious looking  microlobulated mass with few peripheral 
microcalcifications (BI-RADS III/IVa). (arrow) 
 
 
(Fig.a):CC view of both breasts 
 
 
(Fig.b): Magnified image of left breast 
mass 
Sonographic findings  
 (Fig.c):US of the  one  of the right  UOQ  masses showing  marco  lobulated broad and tall 
hypoechoic mass casting posterior shadowing with lower border partially ill defined margin 
(BI-RADS IVa). 
(Fig.d): US of the left breast showing well-defined taller than wider  isoechoic to hypoechoic 
small mass with wall enhancement(BI-RADS III). 
 
(Fig.c):US of right UOQ mass 
 
(Fig.d):US of the left breast mass 
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Dynamic MRM findings: 
 
 (Fig.e):  Subtracted  MR  image  showing  right  UOQ  indistinct  heterogeneously  enhancing 
masses, some of them show fine spicules .  
(Fig.f):  Post  contrast  T1  WI  fat  suppression  at  1  minute  showing  left  IQ  small  defined 
lobulated intense homogenously enhanced mass. 
(Fig.g,h):  Time  /signal  intensity  curves  of  the  right  breast  masses  are  malignant  type  III 
curves  with  initial signal  increase >100% and rapid wash  out ,while the  left breast  mass 
exhibiting benign rising curve (type  I). Right breast masses (BI-RADS V), left breast mass 
(BI-RADS II). 
 
(Fig. e):Subtracted T1WI images showing 
multiple right UOQ enhancing  masses 
 
(Fig. f): Post contrast T1WI  showing left 
IQ small mass 
 
 
(Fig g):Time /signal intensity curve type III  
Wash out 
 
 
(Fig.h):Time /signal intensity curve type I                 
Progressive rise 
 
Pathology 
Right breast invasive ductal carcinoma Grade II.  
Bilateral fibroadenoma. 
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